microRNA‐128‐3p overexpression inhibits breast cancer stem cell characteristics through suppression of Wnt signalling pathway by down‐regulating NEK2

Tumor suppressor miR-128-3p inhibits metastasis and epithelial–mesenchymal transition by targeting ZEB1 in esophageal squamous-cell cancer

(2018) Lili Zhao et al.   ACTA BIOCHIMICA ET BIOPHYSICA SINICA

Functional transcriptomic annotation and protein–protein interaction network analysis identify NEK2, BIRC5, and TOP2A as potential targets in obese patients with luminal A breast cancer

(2018) Miriam Nuncia-Cantarero et al.   BREAST CANCER RESEARCH AND TREATMENT

Novel prognostic and predictive microRNA targets for triple-negative breast cancer

(2018) Gulisa Turashvili et al.   FASEB JOURNAL

TGFβ1 regulates HGF-induced cell migration and hepatocyte growth factor receptor MET expression via C-ets-1 and miR-128-3p in basal-like breast cancer

(2018) Christian Breunig et al.   Molecular Oncology

Importance of protein flexibility on molecular recognition: modeling binding mechanisms of aminopyrazine inhibitors to Nek2

(2018) Xinyi Tang et al.   PHYSICAL CHEMISTRY CHEMICAL PHYSICS

MicroRNA expression in benign breast tissue and risk of subsequent invasive breast cancer

(2018) Thomas Rohan et al.   PLoS One

Association of miR-548c-5p, miR-7-5p, miR-210-3p, miR-128-3p with recurrence in systemically untreated breast cancer

(2018) Ines Block et al.   Oncotarget

Combination of anthracyclines and anti-CD47 therapy inhibit invasive breast cancer growth while preventing cardiac toxicity by regulation of autophagy

(2018) Yismeilin R. Feliz-Mosquea et al.   BREAST CANCER RESEARCH AND TREATMENT

Clinicopathological and prognostic significance of Ras association and pleckstrin homology domains 1 (RAPH1) in breast cancer

(2018) Sasagu Kurozumi et al.   BREAST CANCER RESEARCH AND TREATMENT

Local and whole-body staging in patients with primary breast cancer: a comparison of one-step to two-step staging utilizing 18F-FDG-PET/MRI

(2018) Julian Kirchner et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Co-inhibition of mTORC1, HDAC and ESR1α retards the growth of triple-negative breast cancer and suppresses cancer stem cells

(2018) Andrew Sulaiman et al.   Cell Death & Disease

Beyond Folliculitis: Recognizing Herpes Gladiatorum in Adolescent Athletes

(2017) Elizabeth Y. Wei et al.   JOURNAL OF PEDIATRICS

MicroRNA-128 suppresses paclitaxel-resistant lung cancer by inhibiting MUC1-C and BMI-1 in cancer stem cells

(2017) Hyebin Koh et al.   Oncotarget

Central spindle proteins and mitotic kinesins are direct transcriptional targets of MuvB, B-MYB and FOXM1 in breast cancer cell lines and are potential targets for therapy

(2017) Patrick Wolter et al.   Oncotarget

The E2F activators control multiple mitotic regulators and maintain genomic integrity through Sgo1 and BubR1

(2017) Miyoung Lee et al.   Oncotarget

MicroRNA-128 promotes apoptosis in lung cancer by directly targeting NIMA-related kinase 2

(2017) Dejian Zhao et al.   Thoracic Cancer

High expressions of LDHA and AMPK as prognostic biomarkers for breast cancer

(2016) Xiaojia Huang et al.   BREAST

Evaluation of human epidermal growth factor receptor 2 ( HER2 ) single nucleotide polymorphisms (SNPs) in normal and breast tumor tissues and their link with breast cancer prognostic factors

(2016) Daniela Furrer et al.   BREAST

SIRT1-mediated transcriptional regulation of SOX2 is important for self-renewal of liver cancer stem cells

(2016) Limei Liu et al.   HEPATOLOGY

The role of photobiomodulation on gene expression of cell adhesion molecules in diabetic wounded fibroblasts in vitro

(2016) Sandra M. Ayuk et al.   JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY

MicroRNA-128-3p impaired water maze learning by suppressing Doublecortin expression in both wild type and Aβ-42 infused mice

(2016) Jinlong Chen et al.   NEUROSCIENCE LETTERS

Increased NEK2 in hepatocellular carcinoma promotes cancer progression and drug resistance by promoting PP1/Akt and Wnt activation

(2016) Sailan Wen et al.   ONCOLOGY REPORTS

MicroRNA-1229 overexpression promotes cell proliferation and tumorigenicity and activates Wnt/β-catenin signaling in breast cancer

(2016) Zhanyao Tan et al.   Oncotarget

Tumor cell migration screen identifies SRPK1 as breast cancer metastasis determinant

(2015) Wies van Roosmalen et al.   JOURNAL OF CLINICAL INVESTIGATION

miR-128-3p suppresses hepatocellular carcinoma proliferation by regulating PIK3R1 and is correlated with the prognosis of HCC patients

(2015) CHAO-YUAN HUANG et al.   ONCOLOGY REPORTS

Nek2 activation of Kif24 ensures cilium disassembly during the cell cycle

(2015) Sehyun Kim et al.   Nature Communications

Silencing of E2F3 suppresses tumor growth of Her2+ breast cancer cells by restricting mitosis

(2015) Miyoung Lee et al.   Oncotarget

Oct-4 and nanog promote the epithelial-mesenchymal transition of breast cancer stem cells and are associated with poor prognosis in breast cancer patients

(2015) Dan Wang et al.   Oncotarget

E2F Activators Signal and Maintain Centrosome Amplification in Breast Cancer Cells

(2014) M.-Y. Lee et al.   MOLECULAR AND CELLULAR BIOLOGY

Novel small molecules disrupting Hec1/Nek2 interaction ablate tumor progression by triggering Nek2 degradation through a death-trap mechanism

(2014) C-M Hu et al.   ONCOGENE

Up-regulation of NEK2 by MicroRNA-128 Methylation is Associated with Poor Prognosis in Colorectal Cancer

(2013) Yusuke Takahashi et al.   ANNALS OF SURGICAL ONCOLOGY

Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease

(2009) Ana I. Rojo et al.   GLIA